BackgroundImmunotherapy has changed the therapeutic landscape of cervical cancer (CC), but has durable anti-tumor activity only in a subset of patients. This study aims to comprehensively analyze the
Results of both univariate and multivariate cox regression analyses for total patients and subgroups with low and high ESR2 expression in the validation cohort.
